| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/04/1994 | US5352779 N-linked oligosaccharide chain of glycoprotein coded by DNA molecule eliminated from amino acid position 52 and/or 78 of the alpha subunit |
| 10/04/1994 | US5352778 Prepared from the DNA sequence coding for Thermococcus litoralis DNA polymerase |
| 10/04/1994 | US5352777 Treating with aqueous solution of xanthate-forming compound |
| 10/04/1994 | US5352775 Diagnosis, therapy cancer |
| 10/04/1994 | US5352769 Genetic engineering |
| 10/04/1994 | US5352661 Bacillus thuringiensis isolate denoted B.t. PS81GG, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 10/04/1994 | US5352609 Cartridge, apparatus, and method for preparing purified nucleic acids from a cell sample |
| 10/04/1994 | US5352605 From cauliflower mosaic virus |
| 10/04/1994 | US5352604 Alkaline proteolytic enzyme and method of production |
| 10/04/1994 | US5352603 Highly alkaline proteases |
| 10/04/1994 | US5352600 Purified thermostable enzyme |
| 10/04/1994 | US5352599 Co-enzyme-independent L-sorbosone dehydrogenase of gluconobacter oxydans: isolation, characterization, and cloning and autologus expression of the gene |
| 10/04/1994 | US5352594 Selection and method of making enzymes for perhydrolysis system and for altering substrate specificity, specific activity and catalytic efficiency |
| 10/04/1994 | US5352588 Isolated DNA molecule |
| 10/04/1994 | US5352587 Genetic engineering |
| 10/04/1994 | US5352584 Radioimmunoassay or enzyme-linked immunosorbent assay for qunatitative analysis |
| 10/04/1994 | US5352451 Biological insect control agents and methods of use |
| 10/01/1994 | CA2120476A1 Polypeptide and dnas encoding it |
| 10/01/1994 | CA2120065A1 Oilseed crops producing valuable seeds having altered amino acid composition and fatty acid composition |
| 09/30/1994 | WO1993019172A1 Methods for producing members of specific binding pairs |
| 09/30/1994 | CA2131151A1 Methods for producing members of specific binding pairs |
| 09/30/1994 | CA2119089A1 Tumor necrosis factor muteins |
| 09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
| 09/29/1994 | WO1994021825A1 Combinatorial oligomer immunoabsorbant screening assay for transcription factors and other biomolecule binding |
| 09/29/1994 | WO1994021822A1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 09/29/1994 | WO1994021819A1 Solid-phase anchor carrying nucleic acid and method of adjusting the same |
| 09/29/1994 | WO1994021818A1 Process for typing hla-b using specific primers and probes sets |
| 09/29/1994 | WO1994021814A1 Antibodies and assays for determining mutations in the apc gene |
| 09/29/1994 | WO1994021812A2 Hepatitis b escape mutant specific binding molecules |
| 09/29/1994 | WO1994021811A1 Thermostable dna topoisomerase v |
| 09/29/1994 | WO1994021810A1 PRODUCTION OF POLY-β-HYDROXYBUTYRATE IN PROKARYOTIC HOST CELLS |
| 09/29/1994 | WO1994021809A1 Monocyte or macrophage migration factor |
| 09/29/1994 | WO1994021808A1 Process for preparing cancer vaccines |
| 09/29/1994 | WO1994021807A2 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 09/29/1994 | WO1994021806A1 Delivery system controlled through factors associated with hiv and cell |
| 09/29/1994 | WO1994021805A2 Method of controlling insects in plants |
| 09/29/1994 | WO1994021804A1 Methods and compositions for controlling plant development |
| 09/29/1994 | WO1994021803A2 Fruit ripening-related tomato dna, dna constructs, cells and plants derived therefrom |
| 09/29/1994 | WO1994021802A1 PICHIA PASTORIS ALCOHOL OXIDASE ZZA1 and $i(ZZA2) |
| 09/29/1994 | WO1994021801A2 Purification and molecular cloning of eg iii cellulase |
| 09/29/1994 | WO1994021800A2 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | WO1994021799A1 USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 09/29/1994 | WO1994021798A1 Stimulation of immune response by viral protein |
| 09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
| 09/29/1994 | WO1994021796A2 Maize chlorotic dwarf virus and resistance thereto |
| 09/29/1994 | WO1994021795A1 Novel pesticidal proteins and strains |
| 09/29/1994 | WO1994021794A1 Dna, dna constructs, cells and plants derived therefrom |
| 09/29/1994 | WO1994021793A1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter |
| 09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | WO1994021791A1 Agents for the prevention and treatment of breast cancer |
| 09/29/1994 | WO1994021790A1 Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene |
| 09/29/1994 | WO1994021789A1 Expression of heterologous polypeptides in halobacteria |
| 09/29/1994 | WO1994021787A1 Method for defined deletions of dna |
| 09/29/1994 | WO1994021786A1 An enzyme with pectin lyase activity |
| 09/29/1994 | WO1994021785A1 Enzymes with xylanase activity from aspergillus aculeatus |
| 09/29/1994 | WO1994021784A1 Stromelysin-1 deficient transgenic mice |
| 09/29/1994 | WO1994021783A1 Transcription factor for regulation of the development of skin and hair |
| 09/29/1994 | WO1994021782A2 Dna isolation method |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021687A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 09/29/1994 | WO1994021685A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | WO1994021681A1 Growth differentiation factor-8 |
| 09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 09/29/1994 | WO1994021679A1 Inhibitor of vascular endothelial cell growth factor |
| 09/29/1994 | WO1994021678A1 Hepatic parenchymal cell growth substance |
| 09/29/1994 | WO1994021675A2 T cell epitopes of ryegrass pollen allergen |
| 09/29/1994 | WO1994021672A1 Novel antimicrobial peptides from bovine neutrophils |
| 09/29/1994 | WO1994021670A1 Human serotonin receptors, dna encoding the receptors, and uses thereof |
| 09/29/1994 | WO1994021666A1 Antisense molecules directed against a gene for the catalytic subunit of phosphatidylinositol 3-kinase |
| 09/29/1994 | WO1994021664A1 Antisense molecules directed against a tenascin gene |
| 09/29/1994 | WO1994021663A1 Dinucleotide restriction endonuclease preparations and methods of use |
| 09/29/1994 | WO1994021661A1 Cellular regulation with riboregulators |
| 09/29/1994 | WO1994021660A1 Cloned human alpha1c adrenergic receptor |
| 09/29/1994 | WO1994021300A2 Novel agent for controlling cell activity |
| 09/29/1994 | WO1994021291A1 Chlamydia vaccine and process |
| 09/29/1994 | WO1994021290A1 High molecular weight surface proteins of non-typeable haemophilus |
| 09/29/1994 | WO1994021283A1 Method for inhibiting pulmonary oxygen toxicity using manganese superoxide dismutase |
| 09/29/1994 | WO1994021243A1 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity |
| 09/29/1994 | WO1994021126A1 Nucleic acid coding for a tumor rejection antigen precursor |
| 09/29/1994 | WO1994021118A1 Gene-therapy composition and method for treating carcinomas |
| 09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | WO1994021111A1 Transgenic mammalian as disease model |
| 09/29/1994 | WO1994019454A3 An amylolytic enzyme |
| 09/29/1994 | WO1994018316A3 Apolipoprotein b mrna editing protein compositions and methods |
| 09/29/1994 | WO1994017792A3 Compositions and methods for transdermal drug delivery |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/29/1994 | WO1994011522A3 Vector for the expression of therapy-relevant genes |
| 09/29/1994 | DE4309248A1 Modification of metal oxides with polyphosphates or similar compounds and use thereof |
| 09/29/1994 | CA2159085A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | CA2158939A1 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | CA2158918A1 Process for isolating genes and the gene causative of huntington's disease and differential 3'polyadenylation in the gene |
| 09/29/1994 | CA2158866A1 Hepatitis b escape mutant specific binding molecules |
| 09/29/1994 | CA2158727A1 Parenchymal hepatocyte growth substances |
| 09/29/1994 | CA2158658A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | CA2158655A1 Process for preparing cancer vaccines |
| 09/29/1994 | CA2158647A1 Conjugate containing botulinum toxin translocation and effector domains and heterologocus binding domain for the targeted control of cell activity |
| 09/29/1994 | CA2158642A1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 09/29/1994 | CA2158584A1 Methods and compositions for controlling plant development |
| 09/29/1994 | CA2158564A1 Parvovirus receptors and methods of use |